Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
for Advanced Fallopian Tube Carcinoma
3 locations incl. Scottsdale
Sponsor: Mayo Clinic
Sex: Female·Age: 18+
Code: NCT06639074·Phase 2·Recruiting